Nuzenio

Madrigal Pharmaceuticals

Madrigal Pharmaceuticals news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 8 publisher sources 100/100 entity strength

Latest news

Timeline

Sat, 08 Aug 2026 08:08:28 GMTBank of America Corp DE Sells 226,498 Shares of Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Thu, 06 Aug 2026 20:05:00 GMTMadrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Thu, 06 Aug 2026 14:15:48 GMTMadrigal’s Aug. 11 Investor Presentation Will Be Webcast Live - Stock Titan
Thu, 06 Aug 2026 12:00:00 GMTMadrigal Pharmaceuticals to Participate in the Canaccord Genuity 45th Annual Growth Conference - Yahoo Finance Singapore
Thu, 06 Aug 2026 06:36:34 GMTMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Wed, 05 Aug 2026 09:47:42 GMTCalifornia State Teachers Retirement System Buys 3,039 Shares of Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Madrigal Pharmaceuticals.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.